Effect of apolipoprotein E genotype on lipid levels and response to diet in familial hypercholesterolemia

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 10, Issue 1, 2000, Pages 7-13

  Carmena Ramon R ^a,c   Real, J T ^a   Ascaso, J F ^a   Ordovas J M ^b   Carmena, R ^a  

^a HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^b TUFTS UNIVERSITY   (United States)

^c UNIVERSITY OF VALENCIA   (Spain)

Author keywords

ApoE genotype; Dietary response; Familial hypercholesterolemia; Lipid levels

Indexed keywords

APOLIPOPROTEIN B; APOLIPOPROTEIN E; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BLOOD; DIET THERAPY; FEMALE; GENETIC POLYMORPHISM; GENETICS; GENOTYPE; HUMAN; HYPERLIPOPROTEINEMIA TYPE 2; LOW FAT DIET; MALE; MIDDLE AGED;

ADULT; AGED; APOLIPOPROTEINS B; APOLIPOPROTEINS E; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DIET, FAT-RESTRICTED; FEMALE; GENOTYPE; HUMANS; HYPERLIPOPROTEINEMIA TYPE II; LIPIDS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; TRIGLYCERIDES;

EID: 0034136347     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Schaefer EJ, Gregg RE, Ghiselli G, Forte TM, Ordovas JM, Zech LA, Lindgren FT, Brewer HB Jr (1986) Familial apolipoprotein E deficiency. J Clin Invest 78: 1206-1219
2. Davignon J, Gregg RE, Sing CF (1988) Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis 8: 1-21
3. Sing CF, Davignon J (1985) Role of the apolipoprotein E polymorphism in determining normal plasma lipid and lipoprotein variations. Am J Hum Genet 37: 268-285
4. Xhignesse M, Lussier-Cacan S, Sing CF, Kessling AM, Davignon J (1991) Influence of common variants of apolipoprotein E on measures of lipid metabolism in a sample selected for health. Arterioscler Thromb 98: 201-211
5. Ordovas JM, Litwack-Klein L, Wilson PWF, Schaefer MM, Schaefer EJ (1987) Apolipoprotein E isoform phenotyping methodology and population frequency with identification of apoE1 and apoE5 isoforms. J Lipid Res 28: 371-380
6. Ehnholm C, Lukka M, Kuusi T, Nikkilä E, Uttermann G (1986) Apolipoprotein E polymorphism in the Finnish population: gene frequencies and relation to lipoprotein concentrations. J Lipid Res 27: 227-235
7. Boerwinkle E, Uttermann G (1988) Simultaneous effects of the apolipoprotein E polymorphism on apolipoprotein E, apolipoprotein B, and cholesterol metabolism. Am J Clin Genet 42: 104-112
8. Kesaniemi YA, Ehnholm C, Miettinen TA (1987) Intestinal cholesterol absorption efficiency in man is related to apoprotein E phenotype. J Clin Invest 80: 578-581
9. Miettinen TA, Gylling H, Vanhanen H (1988) Serum cholesterol response to dietary cholesterol and apoprotein E phenotype. Lancet 2: 1261
10. Manttari M, Koskinen P, Ehnholm C, Huttunen JK, Manninen V (1991) Apolipoprotein E polymorphism influences the serum cholesterol response to dietary intervention. Metabolism 40: 217-221
11. Lehtimäki T, Moilanen T, Solakivi T, Laippala P, Ehnholm C (1992) Cholesterol-rich diet-induced changes in plasma lipids in relation to apolipoprotein E phenotype in healthy students. Ann Med 24: 61-66
12. Cobb MM, Teitlebaum H, Risch N, Jekel J, Ostfeld A (1992) Influence of dietary fat, apolipoprotein E phenotype, and sex on plasma lipoprotein levels. Circulation 86: 849-857
13. Boerwinkle E, Brown SA, Rohrbach K, Gotto AM Jr, Patsch W (1991) Role of apolipoprotein E and B gene variation in determining response of lipid, lipoprotein, and apolipoprotein levels to increased dietary cholesterol. Am J Hum Genet 49: 1145-1154
14. Glatz JFC, Demacker PNM, Turner PR, Katan MB (1991) Response of serum cholesterol to dietary cholesterol in relation to apolipoprotein E phenotype. Nutr Metab Cardiovasc Dis 1: 13-17
15. Lahoz C, Osgood D, Wilson PWF, Schaefer EJ, Ordovas JM (1996) Frequency of phenotype-genotype discrepancies at the apolipoprotein E locus in a large population study. Clin Chem 42: 1817-1823
16. Larson IL, Ordovas JM, DeLuca C, Barnard J, Feussner G, Schaefer EJ Effects of apolipoprotein (Apo) E genotype on serum lipoprotein, apoE and glucose levels (In press)
17. Davignon J, Roy M, Dufour R, Roederer G (1991) Familial hypercholesterolemia. In: Steiner G, Shafrir E (eds) Primary Hyperlipoproteinemias. New York, McGraw Hill, pp 201-234
18. Chaves FJ, Puig O, Garcia-Sogo M, Real J, Gil JV, Ascaso JF, Carmena R, Armengod ME (1996). Seven ADN polymorphisms in the LDL receptor gene: application to the study of familial hypercholesterolemia in Spain. Clin Genet 50: 28-35
19. Lombardi P, Sijbrands EJC, van de Giessen K, Smelt AHM, Kastelein JJP, Frants RR, Havekes LM (1995) Mutations in the low density lipoprotein receptor gene of familial hypercholesterolemic patients detected by denaturing gel electrophoresis and direct sequencing. J Lipid Res 36: 860-865
20. Leren TP, Solberg K, Kodningen OK, Ose L, Tondstad S, Berg K (1993) Evaluation of running conditions for SSCP for detection of point mutations in the LDL receptor gene. PCR Methods and applications 3: 159-162
21. Expert Panel on High Blood Cholesterol in Adults (1993) Summary of the second report of the National Cholesterol Educational Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). JAMA 269: 3015-3023
22. American Dietetic Association (1992) Handbook of Clinical Dietetics, 2nd ed. New Haven, Yale University Press, pp 24-25
23. Allain CC, Poon LS, Chan CSG, Richmond W, Fu PC (1974) Enzymatic determination of total serum cholesterol. Clin Chem 20: 470-475
24. Ter BF, Baarscheer T, Fiolet JWT (1984) Influence of free glycerol on enzymatic measurements of triglycerides. Clin Chem 30: 1102-1103
25. Friedewald WT, Levy IR, Fredrickson DS (1972) Estimation of the concentration of low density lipoprotein cholesterol in plasma without use of preparative ultracentrifuge. Clin Chem 18: 499-502
26. Rossenau M, Vercaemst R, Steinberg KK, Cooper GR (1983) Some considerations of methodology and standardization of apolipoprotein B immunoassays. Clin Chem 29: 427-433
27. Hixson JE, Vernier DT (1990) Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with Hhal. J Lipid Res 31: 545-548
28. Gerdes LU, Klausen IC, Sihm I, Faergeman O (1992) Apolipoprotein E polymorphism in a Danish population compared to findings in 45 other study populations around the world. Genet Epidemiol 9: 155-167
29. O'Malley JP, Illingworth DR (1990) The influence of apolipoprotein E phenotype on the response to lovastatin therapy in patients with heterozygous familial hypercholesterolemia. Metabolism 39: 150-154
30. De Knijff P, Stalenhoef AFH, Mol MJMT, Gevers Leuven JA, Smit J, Erkelens DW, Schouten J, Frants RR, Havekes LM (1990) Influence of apo E polymorphism on the response to simvastatin treatment in patients with heterozygous familial hypercholesterolemia. Atherosclerosis 83: 89-97
31. Dallongeville J, Roy M, Leboeuf N, Xhignesse M, Davignon J, Lussier-Cacan S (1991) Apolipoprotein E polymorphism association with lipoprotein profile in endogenous hypertriglyceridemia and familial hypercholesterolemia. Arteriosclerosis 11: 272-278
32. Carmena R, Roederer G, Mailloux H, Lussier-Cacan S, Davignon J (1993) The response to lovastatin treatment in patients with heterozygous familial hypercholesterolemia is modulated by apolipoprotein E polymorphism. Metabolism 42: 895-901
33. Eto M, Watanabe K, Chonan N, Ishii (1988) Familial hypercholesterolemia and apolipoprotein E4. Atherosclerosis 72: 123-128
34. Robertson FW, Cumming AM (1985) Effects of apoprotein E polymorphism on serum lipoprotein concentrations. Arteriosclerosis 5: 283-292
35. Ferrières J, Sing CF, Roy M, Davignon J, Lussier-Cacan S (1994) Apolipoprotein E polymorphism and heterozygous familial hypercholesterolemia. Sex-specific effects. Arterioscler Thromb 14: 1553-1560
36. Ward AJ, O'Kane M, Nicholl DP, Young IS, Nevin NC, Graham CA (1996). A novel single base deletion in the LDLR gene (211 delG): effect on serum lipid profiles and the influence of other genetic polymorphisms in the ACE, APOE, and APOB genes. Atherosclerosis 120: 83-91
37. Katan MB, Beynen AC, de Vries JH, Nobels A (1986) Existence of consistent hypo-and hyperresponders to dietary cholesterol in man. Am J Epidemiol 123: 221-234
38. Jacobs DR, Anderson JT, Hannan P, Keys A, Blackburn H (1983) Variability in individual serum cholesterol response to change in diet. Arteriosclerosis 3: 349-356
39. Beynen AC, Katan MB (1985) Reproducibility of the variations between humans in the response of serum cholesterol to cessation of egg consumption. Atherosclerosis 57: 19-31
40. Abbey M (1992) The influence of apolipoprotein polymorphism on the response to dietary fat and cholesterol. Curr Opin Lipidol 3: 12-16
41. Ordovas JM, Lopez-Miranda J, Mata P, Perez-Jimenez F, Lichtenstein AH, Schaefer EJ (1995) Gene-diet interaction in determining plasma lipid response to dietary intervention. Atherosclerosis 118 (suppl): S11-S27
42. Dreon DM, Krauss RM (1997) Diet-gene interactions in human lipoprotein metabolism. J Am Coll Nutr 4: 313-324
43. Tikkanen MJ, Huttunen JK, Enholm C, Piettinen P (1990) Apolipoprotein E4 homozygosity predisposes to serum cholesterol elevation during high fat diet. Arteriosclerosis 10: 285-288
44. Miettinen TA, Gylling H, Vanhanen H, Ollus A (1992) Cholesterol absorption, elimination, and synthesis related to LDL kinetics during varying fat intake in men with different apoprotein E phenotypes. Arterioscler Thromb 12: 1044-1052
45. López-Miranda J, Ordovas JM, Mata P, Lichtenstein AH, Clevidence B, Judd JT, Schaefer EJ (1994) Effect of apolipoprotein E phenotype on diet-induced lowering of plasma low density lipoprotein cholesterol. J Lipid Res 35: 1965-1975